Vital F

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

Leonurus cardiaca, Quantity: 10 mg (Equivalent: Leonurus cardiaca, Qty 100 mg); Eleutherococcus senticosus, Quantity: 100 mg (Equivalent: Eleutherococcus senticosus, Qty 500 mg); hydrastis canadensis, Quantity: 12.5 mg (Equivalent: hydrastis canadensis, Qty 125 mg); Vitex agnus-castus, Quantity: 20 mg (Equivalent: Vitex agnus-castus, Qty 200 mg); Glycyrrhiza glabra, Quantity: 50 mg (Equivalent: Glycyrrhiza glabra, Qty 400 mg); Arctium lappa, Quantity: 100 mg (Equivalent: Arctium lappa, Qty 400 mg); Trifolium pratense, Quantity: 80 mg (Equivalent: Trifolium pratense, Qty 320 mg); Echinacea purpurea, Quantity: 12.5 mg (Equivalent: Echinacea purpurea, Qty 562.5 mg)

Available from:

Vitex Pharmaceuticals Pty Ltd

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; sorbitol; crospovidone; colloidal anhydrous silica; stearic acid; maltodextrin; titanium dioxide; purified talc; brilliant blue FCF aluminium lake; polyvinyl alcohol; macrogol 3350; lecithin; indigo carmine aluminium lake

Administration route:

Oral

Therapeutic indications:

Maintain/support general health and wellbeing

Product summary:

Visual Identification: ;

Authorization status:

Listed

Authorization date:

2022-01-31